Respiratory Virus Report, Week 38 - ending September 24, 2022

The data in the RVDSS report represent surveillance data available at the time of writing. Data missing from the current week are denoted by N.R. Data not collected by reporting lab denoted by N.C.

The reporting laboratory previously listed as CHEO - Ottawa is now listed as EORLA to better reflect data submitted by this provider.

Specimens from Yukon (YT) are sent to reference laboratories in British Columbia and reported results reflect specimens identified as originating from YT.

Results from British Columbia comprise of specimens from the following sites: BC Children’s and Women’s Hospital, Children's and Women's Hospital Laboratory, Fraser Health Medical Microbiology Laboratory, Island Health, Providence Health Care, Powell River Hospital , St. Paul’s Hospital , Vancouver General Hospital, Victoria General Hospital, BCCDC Public Health Laboratory, Interior Health Authority sites and Northern Health Authority sites.

Delays in the reporting of data may cause data to change retrospectively.

For British Columbia, only data from subtyped influenza A specimens are included in the weekly number of influenza detections. The sum of A(H1N1)pdm09, A(H3), and A(UnS) positive results may not equal the sum of total Flu A positive results.

Due to different testing protocols of laboratories across Canada, influenza A subtype detection counts may not be included in total influenza A detection counts, as some subtype detections are not available through routine testing but are subsequently reported if further subtype testing is conducted. In these instances, subtype counts do not reflect influenza A detections intended to be captured by routine surveillance, and are excluded from total detections and percent positivity.

The data in the RVDSS report represent surveillance data available at the time of writing. Data not collected by reporting lab denoted by N.C.

Note: Included in the cumulative detections this season are 11 co-infections of influenza A and B (total of 22 detections) that are suspected to be associated with recent live attenuated influenza vaccine (LAIV) receipt. Co-infections known or reported to be associated with recent LAIV are removed by the submitting laboratory or by PHAC beginning in week 44 as they do not represent community transmission of seasonal influenza viruses.

The reporting laboratory previously listed as CHEO - Ottawa is now listed as EORLA to better reflect data submitted by this provider.

Specimens from Yukon (YT) are sent to reference laboratories in British Columbia and reported results reflect specimens identified as originating from YT.

Results from British Columbia comprise of specimens from the following sites: BC Children’s and Women’s Hospital, Children's and Women's Hospital Laboratory, Fraser Health Medical Microbiology Laboratory, Island Health, Providence Health Care, Powell River Hospital , St. Paul’s Hospital , Vancouver General Hospital, Victoria General Hospital, BCCDC Public Health Laboratory, Interior Health Authority sites and Northern Health Authority sites.

Delays in the reporting of data may cause data to change retrospectively. Due to these delays, the sum of weekly report totals do not add up to cumulative totals.

For British Columbia, only data from subtyped influenza A specimens are included in the weekly number of influenza detections. The sum of A(H1N1)pdm09, A(H3), and A(UnS) positive results may not equal the sum of total Flu A positive results.

Due to different testing protocols of laboratories across Canada, influenza A subtype detection counts may not be included in total influenza A detection counts, as some subtype detections are not available through routine testing but are subsequently reported if further subtype testing is conducted. In these instances, subtype counts do not reflect influenza A detections intended to be captured by routine surveillance, and are excluded from total detections and percent positivity.